Cargando…
Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
Background: Freezing of gait (FOG) could be partly alleviated by dopaminergic drugs but the mechanism still needs to be elucidated. The purpose of this study is to explore the mechanisms of FOG by vesicular monoamine transporter VMAT2 distribution with the (18)F-AV133 tracer and 18-fludeoxyglucose p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645693/ https://www.ncbi.nlm.nih.gov/pubmed/31410003 http://dx.doi.org/10.2147/NDT.S197879 |
_version_ | 1783437517126631424 |
---|---|
author | Zhou, Yongtao Zhao, Junwu Hou, Yaqin Su, Yusheng Chan, Piu Wang, Yuping |
author_facet | Zhou, Yongtao Zhao, Junwu Hou, Yaqin Su, Yusheng Chan, Piu Wang, Yuping |
author_sort | Zhou, Yongtao |
collection | PubMed |
description | Background: Freezing of gait (FOG) could be partly alleviated by dopaminergic drugs but the mechanism still needs to be elucidated. The purpose of this study is to explore the mechanisms of FOG by vesicular monoamine transporter VMAT2 distribution with the (18)F-AV133 tracer and 18-fludeoxyglucose positron emission tomography–computed tomography ((18)F-FDG PET-CT). Methods: Clinical material and PET-CT data were collected from 20 patients with FOG and 147 patients without FOG from November 1, 2017 to October 31, 2018. Brain scans of all participants were acquired over an approximately 20-min period, 120 min after injection of approximately 250 MBq (18)F-AV133. The mean uptake ratios of different regions were identified by NeuroQ software of (18)F-FDG PET-CT. Data analysis included variance, chi-square analysis, covariance analysis, and logistic regression. Results: Our data showed that patients with FOG were provided with greater doses of dopaminergic drugs (p<0.05). The frequency of FOG was 11.98% and increased as Parkinson’s disease progressed. FOG was more common in the elderly and strongly associated with the duration. Cognitive impairments were obvious, assessed by Mini-Mental State Examination and Montreal Cognitive Assessment (p<0.05). The VMAT2 distribution with (18)F-AV133 was decreased significantly in the caudate nucleus and lentiform nucleus while the metabolism of these areas was elevated, determined by (18)F-FDG PET-CT (p<0.05). The metabolism of the primary visual cortex decreased obviously in patients with FOG compared with those without FOG (p<0.05). Conclusion: FOG mainly occurred in the advanced stage, and was strongly associated with the duration and larger dose of dopaminergic drugs. The dopamine level of the nigrostriatal system decreased significantly and the uptake ratios of the primary visual cortex dropped obviously in the FOG group compared with the non-FOG group. Our study suggests that both the dopaminergic pathway and the primary visual cortex are involved in the pathogenesis of FOG. |
format | Online Article Text |
id | pubmed-6645693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-66456932019-08-13 Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study Zhou, Yongtao Zhao, Junwu Hou, Yaqin Su, Yusheng Chan, Piu Wang, Yuping Neuropsychiatr Dis Treat Original Research Background: Freezing of gait (FOG) could be partly alleviated by dopaminergic drugs but the mechanism still needs to be elucidated. The purpose of this study is to explore the mechanisms of FOG by vesicular monoamine transporter VMAT2 distribution with the (18)F-AV133 tracer and 18-fludeoxyglucose positron emission tomography–computed tomography ((18)F-FDG PET-CT). Methods: Clinical material and PET-CT data were collected from 20 patients with FOG and 147 patients without FOG from November 1, 2017 to October 31, 2018. Brain scans of all participants were acquired over an approximately 20-min period, 120 min after injection of approximately 250 MBq (18)F-AV133. The mean uptake ratios of different regions were identified by NeuroQ software of (18)F-FDG PET-CT. Data analysis included variance, chi-square analysis, covariance analysis, and logistic regression. Results: Our data showed that patients with FOG were provided with greater doses of dopaminergic drugs (p<0.05). The frequency of FOG was 11.98% and increased as Parkinson’s disease progressed. FOG was more common in the elderly and strongly associated with the duration. Cognitive impairments were obvious, assessed by Mini-Mental State Examination and Montreal Cognitive Assessment (p<0.05). The VMAT2 distribution with (18)F-AV133 was decreased significantly in the caudate nucleus and lentiform nucleus while the metabolism of these areas was elevated, determined by (18)F-FDG PET-CT (p<0.05). The metabolism of the primary visual cortex decreased obviously in patients with FOG compared with those without FOG (p<0.05). Conclusion: FOG mainly occurred in the advanced stage, and was strongly associated with the duration and larger dose of dopaminergic drugs. The dopamine level of the nigrostriatal system decreased significantly and the uptake ratios of the primary visual cortex dropped obviously in the FOG group compared with the non-FOG group. Our study suggests that both the dopaminergic pathway and the primary visual cortex are involved in the pathogenesis of FOG. Dove 2019-07-10 /pmc/articles/PMC6645693/ /pubmed/31410003 http://dx.doi.org/10.2147/NDT.S197879 Text en © 2019 Zhou et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhou, Yongtao Zhao, Junwu Hou, Yaqin Su, Yusheng Chan, Piu Wang, Yuping Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study |
title | Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study |
title_full | Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study |
title_fullStr | Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study |
title_full_unstemmed | Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study |
title_short | Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study |
title_sort | dopaminergic pathway and primary visual cortex are involved in the freezing of gait in parkinson’s disease: a pet-ct study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645693/ https://www.ncbi.nlm.nih.gov/pubmed/31410003 http://dx.doi.org/10.2147/NDT.S197879 |
work_keys_str_mv | AT zhouyongtao dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy AT zhaojunwu dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy AT houyaqin dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy AT suyusheng dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy AT chanpiu dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy AT wangyuping dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy |